The molecule invented by the company aims to provide longer-lasting pain relief compared to common treatments of dentin sensitivity, according to an Oct. 4 news release from Mussel Polymers.
Dentin sensitivity affects up to 30 percent of adults worldwide, according to the release.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
